Ensign Peak Advisors, Inc - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,538,000
+21871.4%
41,530
+11436.1%
0.00%
Q2 2022$7,000
-30.0%
3600.0%0.00%
Q1 2022$10,000
+25.0%
3600.0%0.00%
Q4 2021$8,000
-90.2%
360
-85.9%
0.00%
Q4 2020$82,000
-79.4%
2,560
-75.8%
0.00%
-100.0%
Q3 2020$398,000
+38.7%
10,575
+65.0%
0.00%0.0%
Q2 2020$287,0006,4100.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders